Learning Activities

Durvalumab for the Treatment of Advanced Biliary Tract Cancer test

Allan A Lima Pereira, Gabriel Lenz, Tiago Biachi de Castria

Despite being considered a rare type of malignancy, constituting only 3% of all gastrointestinal cancers, the incidence of biliary tract cancers (BTCs) has been increasing worldwide in recent years, with about 20,000 new cases annually only in the USA.1–3 These cancers arise from the biliary epithelium of the small ducts in the periphery of the liver […]

touchREVIEWS in Oncology & Haematology. 2025;21(1):Online ahead of journal publication

Bladder Cancer

Breast Cancer

Colorectal Cancer

COVID-19

Dermatological Cancers

Diagnostics and Screening

Gastrointestinal Cancers

Genitourinary Cancer

Gynaecological Cancers

Haematological Malignancies

Haematology

Head and Neck Cancer

Immunotherapy

Leukaemia

Lung Cancer

Lymphoma

Multiple Myeloma

Endocrine Cancers

Ovarian Cancer

Pancreatic Cancer

Paediatric Oncology

Policy

Prostate Cancer

Renal Cancer

Sarcoma

Supportive Cancer Care

Soft Tissue Tumours

Neuro-oncology

Radiology

Radiotherapy

Rare Diseases

2 mins

CDK4/6 inhibitors in HR+ HER2- EBC: Expert discussions on patient identification, efficacy, and adherence

For HCPs in: Brazil, France and Spain

Watch this touchFEATURE activity to learn more about an upcoming Educational Meeting on CDK4/6 inhibitors in HR+ HER2- EBC.

GM-55294; PP-AL-ES-1312; PP-AL-FR-0871; VV-MED-170513 Date of Preparation: March 2025

Q&A with Dr Benjamin Weinberg: Understanding rare GI cancers (small bowel, appendix and anal cancer)

Rare gastrointestinal (GI) cancers present unique challenges in diagnosis, treatment and research. Dr. Benjamin Weinberg discusses three of the rarest GI cancers: small bowel, appendix and anal cancer.

46 mins

NSCLC disease awareness: unmet needs and diagnostic testing in EGFR-mutated NSCLC

For HCPs in: Global
This activity is funded by AstraZeneca for HCPs only

In this short series of engaging videos, four leading oncology experts discuss current unmet needs in EGFRm NSCLC, the importance of MET diagnostic testing, and treatment options for non-oncogene-addicted NSCLC.

Z2-6556 Date of Preparation: March 2025

Personalized cancer care in geriatric oncology: Insights from SIOG President Dr Grant Williams

Geriatric oncology is at a turning point. With an aging population, integrating geriatric principles into oncology care is more critical than ever. Dr Grant Williams, President of the International Society of Geriatric Oncology (SIOG), is leading efforts to bridge the ...

ASCO #GU25: Top trials you need to know about in prostate cancer

touchONCOLOGY presents the top new clinical trial findings that are generating a buzz among prostate cancer experts. Here’s the latest from one of the leading global conferences in GU oncology: the 2025 ASCO Genitourinary Cancers Symposium (February 26–28, 2025, San Francisco, CA, ...

Personalized care and innovation with Dr Ari Rosenberg:touchONCOLOGY Future Leader 2025

“The patient always comes first – that lesson guides every decision I make” Dr Ari Rosenberg (University of Chicago Medicine, Chicago, IL, USA) specializes in the treatment of head and neck cancer, salivary gland cancer and thyroid cancer. His particular ...

55 mins

Finding the target in METex14 skipping NSCLC – optimizing patient benefit through best practice

For HCPs in: Global

In this activity, watch leading oncology experts discuss recent consensus statements from near-global groups on the diagnosis, testing, and management of METex14 skipping NSCLC.

Date of Preparation: February 2025

34 mins

touchEXPERT OPINIONS

From clinical trials to clinical practice: Applying CDK4/6 inhibitors in HR+/HER2– early breast cancer

Prof. Carlos Barrios, Prof. Dr. med. Peter Fasching, Dr Sonia Pernas

Three experts discuss CDK4/6 inhibitors for the treatment of patients with HR+/HER2– early breast cancer

Translations available:

FDA Priority Review fast-tracks zongertinib for advanced NSCLC patients

The US Food and Drug Administration (FDA) has granted Priority Review for its New Drug Application (NDA) for zongertinib (BI 1810631), a treatment for adults with advanced non-small cell lung cancer (NSCLC) characterized by HER2 (ERBB2) mutations who have undergone prior ...

Project Cure CRC ignites innovation in 2025 with $10.5 million in research, K-SPY debut & renewed RFP

[embed]https://www.youtube.com/watch?v=Cd77dEeZfrc[/embed] As the leading nonprofit organization dedicated to ending the disease, the Colorectal Cancer Alliance (Alliance) continues to break boundaries in colorectal cancer care. Its Project Cure CRC research initiative ...

Embracing Healthy Lifestyles for Cancer Prevention: Reflections from Global Cancer Day

Cancer is a leading cause of death worldwide and represents a growing major public health problem. Every year on February 4, World Cancer Day serves as a global initiative to raise awareness, promote education, and drive action in the fight against ...

Cross-border collaboration is key to reducing inequalities in childhood cancer care

News release in anticipation of International Childhood Cancer Day 2025 Brussels, 15 February 2025 The European childhood cancer community anticipates and celebrates International Childhood Cancer Day by addressing one of the most pressing challenges in paediatric oncology: cross-border access to care and research. ...

FUTURE LEADERS: Shaping the future of cancer treatment with Dr Yuri Yoshinami

“By engaging in research early, young oncologists can contribute to scientific discovery” Q1. What inspired you to pursue a career in oncology? Initially, as a gastroenterologist, I experienced many benign diseases and endoscopic procedures, but oncology was what interested me ...

Welcome to our new Editorial Board members!

Our Editorial Board supports our mission to advance medical knowledge and practice by ensuring the integrity, relevance and impact of the content we publish. Together, we strive to foster a vibrant academic community and contribute to the continuous improvement of ...

World Cancer Day 2025: A new era for cancer and rare disease advocacy in Europe

European Parliament Establishes the Intergroup on Cancer & Rare Diseases The European Parliament has taken a landmark step in prioritizing cancer and rare disease policies by launching the new Intergroup on Cancer & Rare Diseases for the 2024-2029 legislative period. ...

#GI25: Must-know updates in colorectal & pancreatic cancer

What’s new in GI oncology? With the 2025 ASCO Gastrointestinal Cancers Symposium still fresh in our minds, we hear from leading experts on the key abstracts and presentations from the conference in the fields of colorectal and pancreatic cancer. Circulating ...

World Cancer Day 2025: “United by Unique”

World Cancer Day is a campaign run by the Union for International Cancer Control (UICC). It is observed annually on February 4th, and unites the world in the fight against cancer. The theme for 2025–27, "United by Unique", highlights the individual ...

FUTURE LEADERS: Shaping the future of melanoma and sarcoma with Dr Rodrigo Munhoz

"While groundbreaking treatments are transformative, patients often remember the kindness and humanity of their oncologist more than the medicine they receive" Introducing our Future Leaders series, in this interview Dr Rodrigo Munhoz (Oncology Center – Hospital Sírio-Libanês in Sã...

Register Now!

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Save your progress for video
Keep track of your CME credits
Add personalised learning notes
Receive updates from course leaders and faculty
Be the first to hear about new and exciting interactive learning opportunities

Sign Up for Free Access to the
Latest Clinical Updates in Your Specialty!

Conference Coverage

Journals

Durvalumab for the Treatment of Advanced Biliary Tract Cancer test

Conference Coverage

Learning Activities

Journals

Durvalumab for the Treatment of Advanced Biliary Tract Cancer test

touchLearning Activities

CDK4/6 inhibitors in HR+ HER2- EBC: Expert discussions on patient identification, efficacy, and adherence

Q&A with Dr Benjamin Weinberg: Understanding rare GI cancers (small bowel, appendix and anal cancer)

NSCLC disease awareness: unmet needs and diagnostic testing in EGFR-mutated NSCLC

Personalized cancer care in geriatric oncology: Insights from SIOG President Dr Grant Williams

ASCO #GU25: Top trials you need to know about in prostate cancer

Personalized care and innovation with Dr Ari Rosenberg:touchONCOLOGY Future Leader 2025

Finding the target in METex14 skipping NSCLC – optimizing patient benefit through best practice

From clinical trials to clinical practice: Applying CDK4/6 inhibitors in HR+/HER2– early breast cancer

FDA Priority Review fast-tracks zongertinib for advanced NSCLC patients

Project Cure CRC ignites innovation in 2025 with $10.5 million in research, K-SPY debut & renewed RFP

Embracing Healthy Lifestyles for Cancer Prevention: Reflections from Global Cancer Day

Cross-border collaboration is key to reducing inequalities in childhood cancer care

FUTURE LEADERS: Shaping the future of cancer treatment with Dr Yuri Yoshinami

Welcome to our new Editorial Board members!

World Cancer Day 2025: A new era for cancer and rare disease advocacy in Europe

#GI25: Must-know updates in colorectal & pancreatic cancer

World Cancer Day 2025: “United by Unique”

FUTURE LEADERS: Shaping the future of melanoma and sarcoma with Dr Rodrigo Munhoz

Register Now!

Latest articles videos and clinical updates - straight to your inbox

Connect With Us

Useful Links

In Partnership With

Specialities

Sign Up for Free Access to the Latest Clinical Updates in Your Specialty!

Conference Coverage

Learning Activities

Journals

Trending Topic

Connect With Us:

touchLearning Activities

Select Specialty or Clinical Area

Register Now!

Latest articles videos and clinical updates - straight to your inbox

Log into your Touch Account

Register now for FREE Access

Sign up with an Email

This Functionality is forMembers Only

Sign Up for Free Access to the
Latest Clinical Updates in Your Specialty!

This Functionality is for
Members Only